Superior laryngeal nerve block for vocal fold surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with suspected or confirmed benign vocal fold lesions who are scheduled for direct laryngoscopy with lesion excision will receive either a superior laryngeal nerve block containing bupivacaine and triamcinolone or a saline injection during the procedure. Postoperative outcomes such as coughing, pain levels, and voice improvement will be recorded. The comparison of active block versus placebo aims to determine whether the block improves immediate recovery and voice-related symptoms. Participants must be English- or Spanish-speaking and able to consent.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient is aged 18 years or older at time of consent
* Patient has suspected or confirmed benign vocal fold lesion
* Patient is planning to undergo direct laryngoscopy with excision of the vocal fold lesion
* Patient is English or Spanish speaking
* Patient is not pregnant per self report
* Patient is not incarcerated

Exclusion Criteria:

* Patient is not 18 years of age or older at consent date
* Patient does not speak English or Spanish
* Patient is currently pregnant or plans to become pregnant prior to their study procedure
* Patient has a laryngeal malignancy or found to find a laryngeal malignancy on final pathology
* Patient will not be undergoing direct laryngoscopy with excision of lesion
* Patient is unable to provide consent or complete study activities
* Patient is incarcerated

Where it's running

• Rutgers New Jersey Medical School
  Newark, New Jersey, United States Recruiting

Study contacts

• Principal investigator: Kenneth Yan, MD, PhD — Rutgers, The State University of New Jersey
• Study coordinator: Emma Thompson, MD
• Email: ert46@njms.rutgers.edu
• Phone: 973-972-2548

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ctDNA-guided stopping of immune therapy in advanced melanoma

  This study tests whether stopping immune checkpoint inhibitor therapy after 12 months is safe for patients with advanced melanoma who have undetectable ctDNA and disease control.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT07830225

• Personalized brain-targeted TMS for smoking cessation

  A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.

  Recruiting Rutgers, The State University of New Jersey · Newark, New Jersey · NCT07812753

• Luminal Bladder Cancer: Testing Neoadjuvant Therapy vs Immediate Surgery in Luminal MIBC

  We’re testing whether moving straight to radical cystectomy is safe and effective for patients with luminal muscle-invasive bladder cancer compared to the standard neoadjuvant therapy followed by surgery.

  Recruiting Phase 2 Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT07762586

• Genetics of Blood Cancers in the U.S. population

  This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.

  Recruiting Rutgers, The State University of New Jersey · Piscataway, New Jersey · NCT07714044

• Sun Safe Together: a digital skin cancer prevention approach for teens and their parents

  A small, single-arm trial will test whether a 12-week digital program using teen MMS messages and a private Facebook group for parents can feasibly and acceptably improve sun safety among adolescents and their parents.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey · NCT07681791

• Exercise and nasal insulin in Type 2 diabetes: does adding insulin spray help the brain more

  In older adults with Type 2 diabetes, researchers are testing whether combining regular exercise with an intranasal insulin spray improves brain blood flow and thinking abilities more than exercise with a placebo spray.

  Recruiting at 4 sites Phase 2/3 Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 3 other locations · NCT07675499

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.